Allogeneic stem cell transplantation in a blast-phase chronic myeloid leukemia patient with carbapenem-resistant tricuspid valve endocarditis: A case report.

In chronic myeloid leukemia (CML), the occurrence of blastic transformation is rare. Treatment outcome is generally poor. Allogeneic stem cell transplantation (allo-SCT) is the only potentially curative treatment option for advanced-phase CML.